A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 458 participants.

Also called NCT05427786

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 458 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05427786
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05427786. Randomized; no masking; primary purpose prevention. Start 2022-12-14 (actual); primary completion 2027-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease
Condition
No-Reflow Phenomenon
Intervention (Drug)
Nicorandil
Lead sponsor
Korea University Anam Hospital (class: other)
Collaborator
Hanyang University Seoul Hospital (class: other)
Collaborator
InjeUniversityIlsanPaikHospital (class: not stated)
Collaborator
Ajou University School of Medicine (class: other)

Record details

Record id
cardio:ct-nct05427786
Content hash
bcc1a46d5eaaf43f3463f5ba7622b0ef2e9f91198460604b62375c8c02c14bc7